Home/Pipeline/Mycophenolate Mofetil for Oral Suspension

Mycophenolate Mofetil for Oral Suspension

Immunosuppression (e.g., organ transplant rejection)

ANDA ApprovedCommercial

Key Facts

Indication
Immunosuppression (e.g., organ transplant rejection)
Phase
ANDA Approved
Status
Commercial
Company

About Lannett

Lannett is a publicly traded, established generic drug manufacturer with a mission to deliver safe, effective, and affordable medications through a patient-first philosophy. Its strategy is built on a foundation of cost-effective manufacturing, regulatory expertise, and strategic partnerships, including a growing CDMO business. The company's longevity and recent approvals for complex dosage forms, like powders for oral suspension, demonstrate its operational resilience and capability to navigate a challenging market.

View full company profile